EichorEICHOR
Study identifier: NCT07093801 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Recruiting

Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer

Condition: Metastatic Castration Resistant Prostate Cancer  ·  Sponsor: Novartis Pharmaceuticals

PhaseN/A
Planned participants300
Who can joinMale, 18 Years to 99 Years
Healthy volunteersNo

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

This is a local prospective, multicenter, long-term, non-interventional study using primary data collection to describe the routine clinical practice of patients with mCRPC treated with lutetium (177Lu) vipivotide tetraxetan. The observation period will be from date of start of treatment up to a maximum of 18 months after end of treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals  ·  +41613241111  ·  novartis.email@novartis.com

Novartis Pharmaceuticals

Always discuss trial participation with your own doctor first.

Locations (34)

Novartis Investigative SiteAlessandria, AL, ItalyRecruiting
Novartis Investigative SiteAsti, AT, ItalyRecruiting
Novartis Investigative SiteBergamo, BG, ItalyRecruiting
Novartis Investigative SiteBrescia, BS, ItalyRecruiting
Novartis Investigative SiteCatania, CT, ItalyRecruiting
Novartis Investigative SiteMeldola, FC, ItalyRecruiting
Novartis Investigative SiteCona, FE, ItalyRecruiting
Novartis Investigative SiteFoggia, FG, ItalyRecruiting
Novartis Investigative SiteFlorence, FI, ItalyRecruiting
Novartis Investigative SiteGenova, GE, ItalyRecruiting
Novartis Investigative SiteGenova, GE, ItalyRecruiting
Novartis Investigative SiteLatina, LT, ItalyRecruiting

+ 22 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07093801